CPHI China 2025 Grand Occasion Review

On June 26, the three-day CPHI China 2025 ended successfully with a full load of participants. This year's CPHI China held more than 100 high-end conference activities - including special forums, selected buyer matching meetings, ceremony dinners, innovative product showcases, exploration tours and factory visits, etc., focusing on hot topics such as pharmaceutical policy interpretation, trend analysis, cutting-edge technology, and intelligent manufacturing. International exhibitors and new exhibitors showed a vigorous trend of sustained growth, fully demonstrating the leap in the internationalization level of CPHI China.

During the exhibition, ECHEMI actively participated in the exhibition, fully invested in a series of activities, and conducted in-depth and fruitful exchanges with domestic and foreign counterparts. Through product display, buyer matching meetings, business negotiations and other forms, ECHEMI fully demonstrated its professional strength and digital innovation capabilities in the field of pharmaceutical raw materials.

Through the exhibition, ECHEMI has formed a number of specific cooperation intentions with global buyers. High-quality pharmaceutical products, trade data and membership services have also attracted more corporate attention, laying the foundation for subsequent business expansion.

At the CPHI China exhibition, ECHEMI actively played the role of resource integrator and synergist, set up professional global buyer matching activities, and effectively promoted cross-regional cooperation and resource sharing in the pharmaceutical industry. While facilitating reliable cooperation between Chinese suppliers and international buyers, this event also significantly improved customers' recognition of the service value of the ECHEMI platform.

As an important hub in the global pharmaceutical field, CPHI China provides a high-quality platform for domestic pharmaceutical companies to enter the international market. This exhibition has brought together the pioneers of the global pharmaceutical industry, deeply linked the international market and high-quality resources, and led the Chinese pharmaceutical industry to continue to climb to the high end of the value chain.

ECHEMI will continue to play a key role as a platform and resource hub, and work hand in hand with CPHI to plan more innovative activities and matching mechanisms for the next exhibition. We sincerely invite more industry partners to join us in the 2026 CPHI China event and create a new chapter of win-win cooperation!